Thus, unlike solvent-based paclitaxel, nab-paclitaxel exploits albumin to carry paclitaxel directly into cancer cells through a receptor-utilized carrier system, enhancing paclitaxel distribution at the tumor site [16]. This evidence concerns the gene ALB and cancer.